1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Indirect Immunofluorescence 1.2.3 Enzyme-linked Immunosorbent Assay (ELISA) 1.2.4 Other 1.3 Market by Application 1.3.1 Global Anti-nuclear Antibody (ANA) Testing Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Hospital 1.3.3 Clinic 1.3.4 Other 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Anti-nuclear Antibody (ANA) Testing Market Perspective (2016-2027) 2.2 Anti-nuclear Antibody (ANA) Testing Growth Trends by Regions 2.2.1 Anti-nuclear Antibody (ANA) Testing Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 Anti-nuclear Antibody (ANA) Testing Historic Market Share by Regions (2016-2021) 2.2.3 Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Regions (2022-2027) 2.3 Anti-nuclear Antibody (ANA) Testing Industry Dynamic 2.3.1 Anti-nuclear Antibody (ANA) Testing Market Trends 2.3.2 Anti-nuclear Antibody (ANA) Testing Market Drivers 2.3.3 Anti-nuclear Antibody (ANA) Testing Market Challenges 2.3.4 Anti-nuclear Antibody (ANA) Testing Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Anti-nuclear Antibody (ANA) Testing Players by Revenue 3.1.1 Global Top Anti-nuclear Antibody (ANA) Testing Players by Revenue (2016-2021) 3.1.2 Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Players (2016-2021) 3.2 Global Anti-nuclear Antibody (ANA) Testing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Anti-nuclear Antibody (ANA) Testing Revenue 3.4 Global Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio 3.4.1 Global Anti-nuclear Antibody (ANA) Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Anti-nuclear Antibody (ANA) Testing Revenue in 2020 3.5 Anti-nuclear Antibody (ANA) Testing Key Players Head office and Area Served 3.6 Key Players Anti-nuclear Antibody (ANA) Testing Product Solution and Service 3.7 Date of Enter into Anti-nuclear Antibody (ANA) Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Anti-nuclear Antibody (ANA) Testing Breakdown Data by Type 4.1 Global Anti-nuclear Antibody (ANA) Testing Historic Market Size by Type (2016-2021) 4.2 Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Type (2022-2027) 5 Anti-nuclear Antibody (ANA) Testing Breakdown Data by Application 5.1 Global Anti-nuclear Antibody (ANA) Testing Historic Market Size by Application (2016-2021) 5.2 Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Anti-nuclear Antibody (ANA) Testing Market Size (2016-2027) 6.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type 6.2.1 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) 6.2.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) 6.2.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2027) 6.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application 6.3.1 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) 6.3.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) 6.3.3 North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2027) 6.4 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country 6.4.1 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) 6.4.2 North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size (2016-2027) 7.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type 7.2.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) 7.2.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) 7.2.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2027) 7.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application 7.3.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) 7.3.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) 7.3.3 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2027) 7.4 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country 7.4.1 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) 7.4.2 Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size (2016-2027) 8.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type 8.2.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) 8.2.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) 8.2.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2027) 8.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application 8.3.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) 8.3.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) 8.3.3 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2027) 8.4 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region 8.4.1 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2016-2021) 8.4.2 Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size (2016-2027) 9.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type 9.2.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) 9.2.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) 9.2.3 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2027) 9.3 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application 9.3.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) 9.3.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) 9.3.3 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2027) 9.4 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country 9.4.1 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) 9.4.2 Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size (2016-2027) 10.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type 10.2.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) 10.2.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) 10.2.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2027) 10.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application 10.3.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) 10.3.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) 10.3.3 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2027) 10.4 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country 10.4.1 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) 10.4.2 Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Abcam 11.1.1 Abcam Company Details 11.1.2 Abcam Business Overview 11.1.3 Abcam Anti-nuclear Antibody (ANA) Testing Introduction 11.1.4 Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.1.5 Abcam Recent Development 11.2 Antibodies 11.2.1 Antibodies Company Details 11.2.2 Antibodies Business Overview 11.2.3 Antibodies Anti-nuclear Antibody (ANA) Testing Introduction 11.2.4 Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.2.5 Antibodies Recent Development 11.3 Bio-Rad Laboratories 11.3.1 Bio-Rad Laboratories Company Details 11.3.2 Bio-Rad Laboratories Business Overview 11.3.3 Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Introduction 11.3.4 Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.3.5 Bio-Rad Laboratories Recent Development 11.4 Alere 11.4.1 Alere Company Details 11.4.2 Alere Business Overview 11.4.3 Alere Anti-nuclear Antibody (ANA) Testing Introduction 11.4.4 Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.4.5 Alere Recent Development 11.5 Erba Diagnostics 11.5.1 Erba Diagnostics Company Details 11.5.2 Erba Diagnostics Business Overview 11.5.3 Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Introduction 11.5.4 Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.5.5 Erba Diagnostics Recent Development 11.6 MBL International 11.6.1 MBL International Company Details 11.6.2 MBL International Business Overview 11.6.3 MBL International Anti-nuclear Antibody (ANA) Testing Introduction 11.6.4 MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.6.5 MBL International Recent Development 11.7 Merck 11.7.1 Merck Company Details 11.7.2 Merck Business Overview 11.7.3 Merck Anti-nuclear Antibody (ANA) Testing Introduction 11.7.4 Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.7.5 Merck Recent Development 11.8 Indur Services 11.8.1 Indur Services Company Details 11.8.2 Indur Services Business Overview 11.8.3 Indur Services Anti-nuclear Antibody (ANA) Testing Introduction 11.8.4 Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.8.5 Indur Services Recent Development 11.9 Trinity Biotech 11.9.1 Trinity Biotech Company Details 11.9.2 Trinity Biotech Business Overview 11.9.3 Trinity Biotech Anti-nuclear Antibody (ANA) Testing Introduction 11.9.4 Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.9.5 Trinity Biotech Recent Development 11.10 Thermo Fisher Scientific 11.10.1 Thermo Fisher Scientific Company Details 11.10.2 Thermo Fisher Scientific Business Overview 11.10.3 Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Introduction 11.10.4 Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.10.5 Thermo Fisher Scientific Recent Development 11.11 Zeus Scientific 11.11.1 Zeus Scientific Company Details 11.11.2 Zeus Scientific Business Overview 11.11.3 Zeus Scientific Anti-nuclear Antibody (ANA) Testing Introduction 11.11.4 Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) 11.11.5 Zeus Scientific Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Anti-nuclear Antibody (ANA) Testing Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Indirect Immunofluorescence Table 3. Key Players of Enzyme-linked Immunosorbent Assay (ELISA) Table 4. Key Players of Other Table 5. Global Anti-nuclear Antibody (ANA) Testing Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 6. Global Anti-nuclear Antibody (ANA) Testing Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global Anti-nuclear Antibody (ANA) Testing Market Size by Regions (2016-2021) & (US$ Million) Table 8. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions (2016-2021) Table 9. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 10. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions (2022-2027) Table 11. Anti-nuclear Antibody (ANA) Testing Market Trends Table 12. Anti-nuclear Antibody (ANA) Testing Market Drivers Table 13. Anti-nuclear Antibody (ANA) Testing Market Challenges Table 14. Anti-nuclear Antibody (ANA) Testing Market Restraints Table 15. Global Anti-nuclear Antibody (ANA) Testing Revenue by Players (2016-2021) & (US$ Million) Table 16. Global Anti-nuclear Antibody (ANA) Testing Market Share by Players (2016-2021) Table 17. Global Top Anti-nuclear Antibody (ANA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2020) Table 18. Ranking of Global Top Anti-nuclear Antibody (ANA) Testing Companies by Revenue (US$ Million) in 2020 Table 19. Global 5 Largest Players Market Share by Anti-nuclear Antibody (ANA) Testing Revenue (CR5 and HHI) & (2016-2021) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Anti-nuclear Antibody (ANA) Testing Product Solution and Service Table 22. Date of Enter into Anti-nuclear Antibody (ANA) Testing Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million) Table 25. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2016-2021) Table 26. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Type (2022-2027) (US$ Million) Table 27. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2022-2027) & (US$ Million) Table 28. Global Anti-nuclear Antibody (ANA) Testing Market Size Share by Application (2016-2021) & (US$ Million) Table 29. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Application (2016-2021) Table 30. Global Anti-nuclear Antibody (ANA) Testing Forecasted Market Size by Application (2022-2027) (US$ Million) Table 31. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Application (2022-2027) & (US$ Million) Table 32. North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million) Table 33. North America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) & (US$ Million) Table 34. North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) (US$ Million) Table 35. North America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) & (US$ Million) Table 36. North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) & (US$ Million) Table 37. North America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) & (US$ Million) Table 38. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million) Table 39. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) & (US$ Million) Table 40. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) (US$ Million) Table 41. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) & (US$ Million) Table 42. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) & (US$ Million) Table 43. Europe Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) & (US$ Million) Table 44. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million) Table 45. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) & (US$ Million) Table 46. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) (US$ Million) Table 47. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) & (US$ Million) Table 48. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2016-2021) & (US$ Million) Table 49. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size by Region (2022-2027) & (US$ Million) Table 50. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million) Table 51. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) & (US$ Million) Table 52. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) (US$ Million) Table 53. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) & (US$ Million) Table 54. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) & (US$ Million) Table 55. Latin America Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) & (US$ Million) Table 56. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2016-2021) (US$ Million) Table 57. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Type (2022-2027) & (US$ Million) Table 58. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2016-2021) (US$ Million) Table 59. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Application (2022-2027) & (US$ Million) Table 60. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2016-2021) & (US$ Million) Table 61. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size by Country (2022-2027) & (US$ Million) Table 62. Abcam Company Details Table 63. Abcam Business Overview Table 64. Abcam Anti-nuclear Antibody (ANA) Testing Product Table 65. Abcam Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 66. Abcam Recent Development Table 67. Antibodies Company Details Table 68. Antibodies Business Overview Table 69. Antibodies Anti-nuclear Antibody (ANA) Testing Product Table 70. Antibodies Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 71. Antibodies Recent Development Table 72. Bio-Rad Laboratories Company Details Table 73. Bio-Rad Laboratories Business Overview Table 74. Bio-Rad Laboratories Anti-nuclear Antibody (ANA) Testing Product Table 75. Bio-Rad Laboratories Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 76. Bio-Rad Laboratories Recent Development Table 77. Alere Company Details Table 78. Alere Business Overview Table 79. Alere Anti-nuclear Antibody (ANA) Testing Product Table 80. Alere Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 81. Alere Recent Development Table 82. Erba Diagnostics Company Details Table 83. Erba Diagnostics Business Overview Table 84. Erba Diagnostics Anti-nuclear Antibody (ANA) Testing Product Table 85. Erba Diagnostics Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 86. Erba Diagnostics Recent Development Table 87. MBL International Company Details Table 88. MBL International Business Overview Table 89. MBL International Anti-nuclear Antibody (ANA) Testing Product Table 90. MBL International Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 91. MBL International Recent Development Table 92. Merck Company Details Table 93. Merck Business Overview Table 94. Merck Anti-nuclear Antibody (ANA) Testing Product Table 95. Merck Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 96. Merck Recent Development Table 97. Indur Services Company Details Table 98. Indur Services Business Overview Table 99. Indur Services Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 100. Indur Services Recent Development Table 101. Trinity Biotech Company Details Table 102. Trinity Biotech Business Overview Table 103. Trinity Biotech Anti-nuclear Antibody (ANA) Testing Product Table 104. Trinity Biotech Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 105. Trinity Biotech Recent Development Table 106. Thermo Fisher Scientific Company Details Table 107. Thermo Fisher Scientific Business Overview Table 108. Thermo Fisher Scientific Anti-nuclear Antibody (ANA) Testing Product Table 109. Thermo Fisher Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 110. Thermo Fisher Scientific Recent Development Table 111. Zeus Scientific Company Details Table 112. Zeus Scientific Business Overview Table 113. Zeus Scientific Anti-nuclear Antibody (ANA) Testing Product Table 114. Zeus Scientific Revenue in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) & (US$ Million) Table 115. Zeus Scientific Recent Development Table 116. Research Programs/Design for This Report Table 117. Key Data Information from Secondary Sources Table 118. Key Data Information from Primary Sources List of Figures Figure 1. Global Anti-nuclear Antibody (ANA) Testing Market Share by Type: 2020 VS 2027 Figure 2. Indirect Immunofluorescence Features Figure 3. Enzyme-linked Immunosorbent Assay (ELISA) Features Figure 4. Other Features Figure 5. Global Anti-nuclear Antibody (ANA) Testing Market Share by Application: 2020 VS 2027 Figure 6. Hospital Case Studies Figure 7. Clinic Case Studies Figure 8. Other Case Studies Figure 9. Anti-nuclear Antibody (ANA) Testing Report Years Considered Figure 10. Global Anti-nuclear Antibody (ANA) Testing Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global Anti-nuclear Antibody (ANA) Testing Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions: 2020 VS 2027 Figure 13. Global Anti-nuclear Antibody (ANA) Testing Market Share by Regions (2022-2027) Figure 14. Global Anti-nuclear Antibody (ANA) Testing Market Share by Players in 2020 Figure 15. Global Top Anti-nuclear Antibody (ANA) Testing Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Anti-nuclear Antibody (ANA) Testing as of 2020 Figure 16. The Top 10 and 5 Players Market Share by Anti-nuclear Antibody (ANA) Testing Revenue in 2020 Figure 17. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2016-2021) Figure 18. Global Anti-nuclear Antibody (ANA) Testing Revenue Market Share by Type (2022-2027) Figure 19. North America Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America Anti-nuclear Antibody (ANA) Testing Market Share by Type (2016-2027) Figure 21. North America Anti-nuclear Antibody (ANA) Testing Market Share by Application (2016-2027) Figure 22. North America Anti-nuclear Antibody (ANA) Testing Market Share by Country (2016-2027) Figure 23. United States Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe Anti-nuclear Antibody (ANA) Testing Market Share by Type (2016-2027) Figure 27. Europe Anti-nuclear Antibody (ANA) Testing Market Share by Application (2016-2027) Figure 28. Europe Anti-nuclear Antibody (ANA) Testing Market Share by Country (2016-2027) Figure 29. Germany Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Share by Type (2016-2027) Figure 37. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Share by Application (2016-2027) Figure 38. Asia-Pacific Anti-nuclear Antibody (ANA) Testing Market Share by Region (2016-2027) Figure 39. China Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America Anti-nuclear Antibody (ANA) Testing Market Share by Type (2016-2027) Figure 47. Latin America Anti-nuclear Antibody (ANA) Testing Market Share by Application (2016-2027) Figure 48. Latin America Anti-nuclear Antibody (ANA) Testing Market Share by Country (2016-2027) Figure 49. Mexico Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Share by Type (2016-2027) Figure 53. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Share by Application (2016-2027) Figure 54. Middle East & Africa Anti-nuclear Antibody (ANA) Testing Market Share by Country (2016-2027) Figure 55. Turkey Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE Anti-nuclear Antibody (ANA) Testing Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Abcam Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 59. Antibodies Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 60. Bio-Rad Laboratories Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 61. Alere Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 62. Erba Diagnostics Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 63. MBL International Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 64. Merck Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 65. Indur Services Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 66. Trinity Biotech Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 67. Thermo Fisher Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 68. Zeus Scientific Revenue Growth Rate in Anti-nuclear Antibody (ANA) Testing Business (2016-2021) Figure 69. Bottom-up and Top-down Approaches for This Report Figure 70. Data Triangulation Figure 71. Key Executives Interviewed

Abcam Antibodies Bio-Rad Laboratories Alere Erba Diagnostics MBL International Merck Indur Services Trinity Biotech Thermo Fisher Scientific Zeus Scientific